17-alpha-hydroxyprogesterone has been researched along with Polycystic Ovarian Syndrome in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (9.19) | 18.7374 |
| 1990's | 52 (28.11) | 18.2507 |
| 2000's | 71 (38.38) | 29.6817 |
| 2010's | 39 (21.08) | 24.3611 |
| 2020's | 6 (3.24) | 2.80 |
| Authors | Studies |
|---|---|
| Dahl, SR; Hessen, S; Husebye, ES; Methlie, P; Thorsby, PM; Ueland, GÅ | 1 |
| Feng, G; Li, R; Xu, H; Yang, L; Zhang, X; Zhao, L; Zhao, R | 1 |
| Araújo, JE; Cardoso, NS; Dutra, SGV; Ferriani, RA; Gastaldi, AC; Ribeiro, VB; Souza, HCD | 1 |
| Bachega, TASS; Baracat, EC; Gomes, LG; Hayashida, SAY; Maciel, GAR; Maffazioli, GDN; Marcondes, JAM; Mendonca, BB; Valassi, HPL | 1 |
| Cao, Z; Cong, Y; Dong, Y; Huang, W; Li, Y; Liu, J; Liu, Y; Lu, Y; Luo, YR; Tang, G; Wang, H; Yin, C; Zhai, Y; Zhang, Q | 1 |
| Apa, R; Cicco, S; Florio, CD; Immediata, V; Lanzone, A; Romualdi, D; Santarsiero, CM; Scarinci, E; Tagliaferri, V; Tropea, A | 1 |
| Davis, AM; Mimoto, MS; Oyler, JL | 1 |
| Chun, S | 1 |
| Pignatelli, D | 1 |
| Barbosa, JS; Gil-Junior, AB; Isaías, ED; Medeiros, SF; Yamamoto, MM | 1 |
| Clarke, N; Goldman, MM; Keefe, CC; Reitz, RE; Welt, CK; Zhang, K | 1 |
| Acikgoz, AS; Gurleyen, HC; Imamoglu, M; Oncul, M; Sahmay, S; Senturk, ML; Tuten, A | 1 |
| Altinok, M; Andersen, M; Buch, K; Glintborg, D; Mumm, H; Ravn, P | 1 |
| Benian, A; Gurleyen, H; Oncul, M; Sahmay, S; Tamer Erel, C; Tuten, A | 1 |
| Aksoy, DY; Cetinozman, F; Cinar, N; Elcin, G; Yildiz, BO | 1 |
| Chang, RJ; Chuan, SS; Cook-Andersen, H; Lawson, M; Maas, K; Mason, HD; Rosencrantz, MA; Su, HI | 1 |
| Chang, RJ; Chuan, SS; Cook-Andersen, H; Duleba, A; Maas, KH; Su, HI | 1 |
| Dunaif, A; Grebe, SK; Legro, RS; Liu, DM; Paparodis, R; Singh, RJ; Sung, Y; Taylor, RL; Torchen, LC | 1 |
| Rosenfield, RL | 1 |
| Hayat, M; Rizwan, A | 1 |
| Drosdzol-Cop, A; Krysiak, R; Okopien, B; Skrzypulec-Plinta, V | 1 |
| Burt-Solorzano, CM; Chang, RJ; Cook-Andersen, H; Hou, J; Kumar, A; Maas, KH; Shayya, R; Su, HI | 1 |
| Chang, RJ; Chuan, S; Cook-Andersen, H; Duleba, AJ; Harrison, E; Maas, KH | 1 |
| da Silva, GM; Lima, SM; Macruz, CF; Salles, JE; Scalissi, NM | 1 |
| Apa, R; Guido, M; Lanzone, A; Miceli, F; Sagnella, F; Spadoni, V; Villa, P | 1 |
| Diedrich, K; Dietze, T; Goharian, LG; Ludwig, AK; Oltmanns, KM; Rudolf, S; Schweiger, U; Tauchert, S | 1 |
| Ahmed, IM; Duleba, AJ | 1 |
| Ehrmann, DA; Littlejohn, E; Mortensen, M; Rosenfield, RL | 1 |
| Dissen, GA; Garcia-Rudaz, C; Mayer, C; Mayerhofer, A; Ojeda, SR; Paredes, A | 1 |
| Brailly-Tabard, S; Khallouf, O; Trabado, S | 1 |
| Carmina, E; Di Fede, G; Mansueto, P; Pepe, I; Rini, GB | 1 |
| Boyko, V; Hemi, R; Kanety, H; Koren, I; Pariente, C; Pilpel, N; Pinhas-Hamiel, O; Singer, S | 1 |
| Atkin, SL; Sathyapalan, T | 1 |
| Berdeli, A; Cetinkalp, S; Erdogan, M; Karadeniz, M; Ozgen, AG; Saygili, F; Tamsel, S; Yilmaz, C | 1 |
| Azziz, R; Beires, J; Pall, M; Pignatelli, D | 1 |
| Check, JH; Mitchell-Williams, J | 1 |
| Baker, TE; Baker, V; Castracane, VD; Kauffman, MM; Kauffman, RP | 1 |
| Caputo, A; Caputo, V; Curiale, S; Fiorella, S; Niceta, M | 1 |
| Bahri, S; Heuser, I; Kronsbein, J; Lammers, CH; Lange, J; Lübbert, H; Merkl, A; Roepke, S; Schweiger, U; Ziegenhorn, A | 1 |
| Anderson, H; Dunaif, A; Fogel, N; Grebe, SK; Singh, RJ; Taylor, RL | 1 |
| Li, W; Liu, YC; Wang, XX | 1 |
| Incki, K; Kelekci, KH; Kelekci, S; Ozdemir, O; Yilmaz, B | 1 |
| Kunicki, M; Radowicki, S; Rudnicka, E | 1 |
| Bae, CS; Hou, L; Kuang, H; Stener-Victorin, E; Wang, Y; Wu, X; Yang, X; Zhang, Y | 1 |
| De Cicco, S; Guido, M; Lanzone, A; Proto, C; Romualdi, D; Tagliaferri, V | 1 |
| Bieńkiewicz, M; Cajdler-Łuba, A; Lewandowski, KC; Lewiński, A; Salata, I | 1 |
| Ciampaglia, W; Cognigni, GE; Fanelli, F; Gambineri, A; Pagotto, U; Pasquali, R; Patton, L; Prontera, O | 1 |
| Aldrighi, JM; Aoki, T; Kowastch, I; Mathias, W; Oliveira, RM; Ribeiro, AL; Scapinelli, A; Tamanaha, S | 1 |
| Andersen, M; Glintborg, D; Hougaard, DM; Mumm, H; Ravn, P | 1 |
| Ehrmann, DA; Littlejohn, E; Mortensen, M; Rosenfield, RL; Wroblewski, K | 1 |
| Lai, MH; Ma, HX; Xie, J | 1 |
| Ferriani, RA; Japur de Sá Rosa-e-Silva, AC; Nascimento, AD; Reis, RM; Silva Lara, LA | 1 |
| Akcali, A; Buduneli, N; Ceyhan, BO; Hannah, V; Lappin, DF; Nile, C; Özçaka, Ö | 1 |
| Elmay, M; Kacem, M; Kacem, SB; Mahjoub, S; Said, M; Youssef, FH | 1 |
| Barontini, M; Escobar, ME; Garcia-Rudaz, MC; Ropelato, MG; Veldhuis, JD | 1 |
| Cheung, AP; Pride, SM; Sy, L; Yuen, BH | 1 |
| Bayram, F; Colak, R; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Andrico, S; Falsetti, L; Gambera, A; Sartori, E | 1 |
| Cengiz, C; Develioğlu, O; Sözer, MC; Uncu, G | 1 |
| Baracat, EC; de Lima, GR; Haidar, MA; Lakryc, EM; Motta, EL; Soares, JM | 1 |
| Colao, A; Dentico, C; Lombardi, G; Nappi, C; Orio, F; Palomba, S; Russo, T; Savastano, S; Sultan, C; Tauchmanovà, L; Zullo, F | 1 |
| Ciampelli, M; Giuliani, M; Guido, M; Lanzone, A; Leoni, F; Perri, C; Romualdi, D | 1 |
| Adiyaman, P; Berberoğlu, M; Cetinkaya, E; Ocal, G | 1 |
| Cockrell, JE; Legro, RS; McAllister, JM; Nelson-DeGrave, VL; Strauss, JF; Wickenheisser, JK; Wood, JR | 1 |
| Azziz, R; Moran, C | 1 |
| Baştemir, M; Corapçioğlu, D; Emral, R; Güllü, S; Kamel, N; Tonyukuk, V | 1 |
| Battaglia, C; Gamba, O; Genazzani, AD; Malavasi, B; Strucchi, C; Tortolani, F | 1 |
| Azziz, R; Bartolucci, AA; Farah-Eways, L; Knochenhauer, ES; Reyna, R | 1 |
| Azziz, R; Boots, LS; Moran, C; Reyna, R | 1 |
| Bellows, AB; Evans, WS; Gingrich, MB; Hu, Y; Marshall, JC; McCartney, CR; Veldhuis, JD | 1 |
| Apa, R; Costantini, B; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Suriano, R | 1 |
| Cartes, A; Echiburú, B; Gutiérrez, C; Maliqueo, M; Petermann, TS; Recabarren, SE; Toloza, H; Vantman, D | 1 |
| Chang, RJ | 2 |
| Andersen, M; Brusgaard, K; Glintborg, D; Hagen, C; Hangaard, J; Hermann, AP | 1 |
| Berker, B; Corapcioglu, D; Demirel, C; Emral, R; Kose, K; Unlu, C | 1 |
| B Wasikowa, R; Wikiera, B | 1 |
| Asteriadis, C; Diamanti-Kandarakis, E; Farmakiotis, D; Karayannis, V; Katsikis, I; Koliakos, G; Kourtis, A; Panidis, D; Rousso, D | 1 |
| Biri, A; Bukan, N; Karakoç, A; Paşaoğlu, H; Sancak, B; Törüner, F; Yilmaz, M | 1 |
| Carmina, E; Jannì, A; Longo, RA; Rizzo, M; Rosato, F | 1 |
| Al-Shoumer, KA; Al-Zaid, M; Doi, SA; Scott, CJ; Towers, PA | 1 |
| Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
| Chang, RJ; Coffler, MS; Malcom, PJ; Wachs, DS | 1 |
| Cassorla, F; Codner, E; Crisosto, N; Echiburú, B; Hitschfeld, C; Maliqueo, M; Pérez-Bravo, F; Recabarren, SE; Sir-Petermann, T | 1 |
| Littlejohn, E; Mortensen, M; Rosenfield, RL | 1 |
| Angioni, S; Apa, R; Belosi, C; Ciampelli, M; Fulghesu, AM; Iuculano, A; Lanzone, A; Melis, GB; Selvaggi, L | 1 |
| Ozyurek, SE; Uncu, G; Uncu, Y | 1 |
| Bahlo, M; Schott, M; Willenberg, HS | 1 |
| Cognigni, GE; Gambineri, A; Pasquali, R; Patton, L; Pocognoli, P | 1 |
| Bahlo, M; Feldkamp, J; Scherbaum, WA; Schott, M; Wertenbruch, T; Willenberg, HS | 1 |
| Azziz, R; Knochenhauer, ES; Yildiz, BO | 1 |
| Cabré, S; Callejo, J; de Zegher, F; Dunger, D; Ibáñez, L; López-Bermejo, A; Torres, A | 1 |
| Farmakiotis, D; Katsikis, I; Kourtis, A; Krassas, G; Panidis, D; Rousso, D | 1 |
| Escobar-Morreale, HF; San Millán, JL; Sanchón, R | 1 |
| Chang, RJ; Coffler, MS; Malcom, PJ; Shimasaki, S; Wachs, DS | 1 |
| Cibula, D; Fanta, M; Vrbíková, J | 1 |
| Azziz, R; Brennan, K; Huang, A | 1 |
| Carmina, E; Gagliano, AM; Indovina, D; Jannì, A; Maggiore, M; Rosato, F | 1 |
| Chang, RJ; Chetkowski, RJ; DeFazio, J; Judd, HL; Meldrum, DR | 1 |
| Conway, AJ; Handelsman, DJ; Howe, CJ; Turtle, JR | 1 |
| Apter, D; Bützow, T; Laughlin, GA; Yen, SS | 1 |
| Bruchis, C; Galatzer, A; Kauli, R; Lazar, L; Nordenberg, J; Pertzelan, A | 1 |
| Donaldson, A; Franks, S; Leigh, A; White, D; Wilson, C | 1 |
| Calderon, I; Healy, DL; MacLachlan, V; McLachlan, RI; Montalto, J; Suikkari, AM | 1 |
| Ardaens, Y; Dewailly, D; Fossati, P; Helin, I; Lemaitre, L; Robert, Y; Thomas-Desrousseaux, P | 1 |
| Chang, L; Ditkoff, EC; Fruzzetti, F; Lobo, RA; Stancyzk, FZ | 1 |
| Carrascosa, A; Gussinyé, M; Ibáñez, L; Potau, N; Prat, N; Saenger, P; Vicens-Calvet, E; Zampolli, M | 1 |
| Gökmen, O; Gülekli, B; Kükner, S; Oral, H; Senöz, S; Turhan, NO | 1 |
| Bicknell, J; Clayton, RN; Jones, M; Rajkhowa, M | 1 |
| Algur, N; Barr, I; Boldes, R; Diamant, YZ; Gal, M; Orly, J | 1 |
| Conte, FA; Fisher, CR; Grumbach, MM; Ito, Y; Simpson, ER | 1 |
| Keleştimur, F; Sahin, Y | 4 |
| Eppel, W; Huber, J; Reinold, E; Schön, HJ; Schurz, B; Wenzl, R | 1 |
| Chryssikopoulos, A; Phocas, I; Rizos, D; Sarandakou, A; Trakakis, E | 1 |
| Jakubowicz, DJ; Nestler, JE | 3 |
| Utiger, RD | 1 |
| Chang, L; Gonzalez, F; Horab, T; Lobo, RA | 1 |
| Carrascosa, A; Hall, JE; Ibañez, L; Potau, N; Prat, N; Taylor, AE | 1 |
| Sakiyama, R | 1 |
| Franks, S | 1 |
| Ayata, D; Keleştimur, F; Sahin, Y | 1 |
| Kocijancic, A; Komel, R; Liović, M; Majdic, G; Prezelj, J | 1 |
| Dorato, M; Lombardi, G; Rossi, R; Savastano, S; Tommaselli, AP; Valentino, R | 1 |
| De Fusco, D; Eleftheriou, G; Falsetti, L; Rosina, B | 1 |
| Franks, S; Gilling-Smith, C; Rogers, V; Story, H | 1 |
| Arroyo, A; Laughlin, GA; Morales, AJ; Yen, SS | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A | 1 |
| Gjønnaess, H | 1 |
| Cariello, PL; D'Antona, D; De Leo, V; la Marca, A; Lanzetta, D; Morgante, G | 1 |
| Colgar, U; Erel, CT; Ertungealp, E; Oral, E; Senturk, LM | 1 |
| Carmina, E; Lobo, RA | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Unlühizarci, K | 1 |
| Allan, G; Gunn, RD; Jakubowicz, DJ; Nestler, JE; Reamer, P | 1 |
| Hirahara, F; Ishikawa, M; Kondoh, Y; Uemura, T; Yokoi, N | 1 |
| Acién, M; Acién, P; Alfayate, R; López-Fernández, JA; Matallín, P; Mauri, M; Quereda, F; Villarroya, E | 1 |
| Daya, S; Dörtlemez, O; Maral, I; Noyan, V; Tíras, MB; Yalcìn, R; Yìldìrìm, M | 1 |
| Arslanian, S; Witchel, SF | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Barontini, M; Castro-Fernandez, C; Escobar, ME; Garcia-Rudaz, MC; Ropelato, MG; Ulloa-Aguirre, A; Veldhuis, JD | 1 |
| Cianci, A; Ciani, A; De Leo, V; Egbe, TO; la Marca, A; Morgante, G; Paglia, T | 1 |
| Caputo, M; Castello, R; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Zanolin, E | 1 |
| Lu, C; Qiao, J; Wang, A | 1 |
| Battaglia, C; Gamba, O; Genazzani, AD; Genazzani, AR; Malavasi, B; Petraglia, F | 1 |
| Bendlová, B; Cibula, D; Hill, M; Pobisová, Z; Snajderová, M; Stárka, L; Sulcová, J; Vondra, K; Vrbíklová, J | 1 |
| Arora, TK; Burt, CM; Eagleson, CA; Evans, WS; Gingrich, MB; Marshall, JC; Pastor, CL | 1 |
| Bidzińska, B; Demissie, M; Milewicz, A; Tworowska, U | 1 |
| Cianci, A; Ciotta, L; Farina, M; Pafumi, C | 1 |
| Cibula, D; Kuzel, D; Rezabek, K; Starka, PL; Vrbikova, J; Zivny, J | 1 |
| Teppa-Garrán, AD; Terán Dávila, J | 1 |
| Calvo, RM; Escobar-Morreale, HF; San Millán, JL; Sancho, J; Villuendas, G | 1 |
| Apa, R; Belosi, C; Ciampelli, M; Fulghesu, AM; Lanzone, A; Pavone, V | 1 |
| Barontini, M; Escobar, ME; Garcia-Rudaz, MC; Pincus, SM; Ropelato, MG; Veldhuis, JD | 1 |
| Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS | 1 |
| Eldar-Geva, T; Groome, NP; Homburg, R; Margalioth, EJ; Spitz, IM | 1 |
| Bendlová, B; Cibula, D; Hill, M; Snajderová, M; Stárka, L; Sulcová, J; Vondra, K; Vrbíková, J | 1 |
| Demant, T; Halser, B; Strowitzki, T | 1 |
| Bashir, MI; Laway, BA; Masoodi, SR; Salahuddin, M; Wani, AI; Zargar, AH | 1 |
| Calvo, RM; Escobar-Morreale, HF; San Millán, JL; Sancho, J; Tellería, D | 1 |
| Kurkowska, M; Małecka-Tendera, E; Wrześniewski, N; Zachurzok, A | 1 |
| Barnes, RB; Brigell, DF; Ehrmann, DA; Rosenfield, RL; Sheikh, Z | 1 |
| Caruso, A; Fortini, A; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S | 1 |
| Brzezinska, A; Jeske, W; Makowska, A; Slowinska-Srzednicka, J; Soszynski, P; Zgliczynski, S; Zgliczynski, W | 1 |
| Alaghband-Zadeh, J; Bojanic, S; Carter, GD; Jones, L; Lake, R; Laycock, JF; Place, J | 1 |
| Azziz, R; Bradley, EL; Rafi, A; Smith, BR; Zacur, HA | 1 |
| Butt, WR; Holder, G; Jackson, R; Lynch, SS; Obhrai, M; Tang, L | 1 |
| Balducci, R; Bianchi, P; Mangiantini, A; Sciarra, F; Toscano, V | 1 |
| Adams, J; Hague, WM; Honour, JW; Jacobs, HS; Vecsei, P | 1 |
| De Cicco, F; Dell'Acqua, S; Lucisano, A; Mobili, L; Monaco, F; Roche, J; Satta, MA; Tripodi, R | 1 |
| Apa, R; Caruso, A; Fulghesu, AM; Guida, C; Lanzone, A; Mancuso, S | 1 |
| Cabezas-Cerrato, J; Devesa, J; Lima, L; Perez-Fernandez, R | 1 |
| Adami, S; Francia, G; Lo Cascio, V; Montesanti, F; Rama, GP | 1 |
| Cobin, RH; Fiedler, RP; Futterweit, W; Thornton, JC | 1 |
| Grabinski, M; Gruszka, S; Milewicz, A; Szymczak, J; Tupikowska, G | 1 |
| Cunningham, SK; Loughlin, T; McKenna, TJ | 1 |
| Benjamin, F; Deutsch, S; Saperstein, H; Seltzer, VL | 1 |
| Culliton, M; Cunningham, S; Loughlin, T; McKenna, TJ; Moore, A; Smyth, PP | 1 |
| Gentile, L; Messina, M; Milani, P | 1 |
| Faure, N; Lemay, A | 1 |
| Buvat, J; Buvat-Herbaut, M; Fossati, P; Fourlinnie, JC; Marcolin, G; Racadot, A | 1 |
| Cohen, RM; Rosenfield, RL; Talerman, A | 1 |
8 review(s) available for 17-alpha-hydroxyprogesterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Cardiovascular Diseases; Diagnosis, Differential; Female; Glucocorticoids; Heterozygote; Hirsutism; Humans; Infertility, Female; Insulin Resistance; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome; Risk Factors; Steroid 21-Hydroxylase | 2013 |
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anovulation; Female; Humans; Hyperandrogenism; Insulin Resistance; Ovary; Phenotype; Polycystic Ovary Syndrome | 2015 |
21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Female; Humans; Hyperandrogenism; Insulin Resistance; Ovary; Ovulation; Polycystic Ovary Syndrome; Steroid 21-Hydroxylase | 2003 |
A practical approach to the diagnosis of polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androgens; Anovulation; Cushing Syndrome; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Hirsutism; Humans; Hyperinsulinism; Insulin Resistance; Obesity; Ovary; Polycystic Ovary Syndrome; Testosterone; Theca Cells; Ultrasonography | 2004 |
Approach to patients with hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Cushing Syndrome; Dehydroepiandrosterone; Female; Hirsutism; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Testosterone | 1996 |
[Polycystic ovary syndrome of extra-ovarian origin. Review].
Topics: 11-beta-Hydroxysteroid Dehydrogenases; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Androgens; Catecholamines; Clomiphene; Corticotropin-Releasing Hormone; Cortisone; Dexamethasone; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Hydroxysteroid Dehydrogenases; Hyperinsulinism; Hyperprolactinemia; Hypothalamo-Hypophyseal System; Infant, Newborn; Infertility, Female; Insulin Resistance; Leptin; Mineralocorticoids; Obesity; Ovary; Ovulation Induction; Pituitary-Adrenal System; Polycystic Ovary Syndrome; Pseudopregnancy; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Steroids; Sterol Esterase; Stress, Psychological | 2001 |
[Polycystic ovaries in 2001: physiology and treatment].
Topics: 17-alpha-Hydroxyprogesterone; Androgen Antagonists; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Exercise; Female; Humans; Hypothalamus; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone; Ultrasonography; Weight Loss | 2002 |
The adrenal cortex and virilization.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Amenorrhea; Androgens; Androstenedione; Clomiphene; Cushing Syndrome; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Hydroxyprogesterones; Infertility, Female; Obesity; Polycystic Ovary Syndrome; Testosterone; Virilism | 1985 |
26 trial(s) available for 17-alpha-hydroxyprogesterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Androstenedione; Anti-Mullerian Hormone; California; Child; Chorionic Gonadotropin; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Injections, Intravenous; Polycystic Ovary Syndrome; Recombinant Proteins; Reproducibility of Results; Testosterone; Virginia | 2016 |
In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Dexamethasone; Female; Follicle Stimulating Hormone; Glucocorticoids; Humans; Infertility, Female; Kinetics; Luteinizing Hormone; Nafarelin; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Recombinant Proteins; Testosterone | 2002 |
A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Enzyme Activation; Female; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase | 2002 |
The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; 5-alpha Reductase Inhibitors; Adult; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Placebos; Polycystic Ovary Syndrome; Prolactin; Testosterone; Ultrasonography | 2003 |
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Body Constitution; Body Mass Index; Female; Follicle Stimulating Hormone; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones | 2003 |
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Area Under Curve; Blood Glucose; C-Peptide; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Luteinizing Hormone; Menstrual Cycle; Metformin; Obesity; Ovary; Polycystic Ovary Syndrome; Testosterone | 2004 |
Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Topics: 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Androstenedione; Case-Control Studies; Cross-Sectional Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Pregnenolone; Progesterone; Prospective Studies; Steroid 17-alpha-Hydroxylase; Testosterone | 2004 |
Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Body Mass Index; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infusions, Intravenous; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pulse Therapy, Drug; Receptors, LHRH; Recombinant Proteins | 2004 |
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Thiazolidinediones | 2004 |
Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Luteinizing Hormone; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Area Under Curve; Dehydroepiandrosterone; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Overweight; Placebos; Polycystic Ovary Syndrome; Rosiglitazone; Sex Hormone-Binding Globulin; Thiazolidinediones | 2006 |
ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Blood Glucose; Dehydroepiandrosterone Sulfate; Factor Analysis, Statistical; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone; Prospective Studies; Testosterone | 2007 |
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2008 |
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Hypoglycemic Agents; Insulin; Leuprolide; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 1996 |
Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gon
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Case-Control Studies; Chorionic Gonadotropin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1996 |
Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Finasteride; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1997 |
Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Anthropometry; Blood Glucose; Body Composition; Female; Gonadal Steroid Hormones; Humans; Insulin; Leuprolide; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase | 1997 |
Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Blood Glucose; Cohort Studies; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Menstruation; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1998 |
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Blood Glucose; Female; Humans; Inositol; Insulin; Lipids; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome | 1999 |
Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Androgens; Clomiphene; Cohort Studies; Corticotropin-Releasing Hormone; Dexamethasone; Female; Gonadotropins, Pituitary; Hirsutism; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Obesity; Ovulation; Pituitary-Adrenal System; Polycystic Ovary Syndrome | 1999 |
Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Chorionic Gonadotropin; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Ovary; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 2000 |
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Buserelin; Cholesterol; Double-Blind Method; Endocrine Glands; Female; Glucose Clamp Technique; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Triglycerides | 2000 |
The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Bone Density; Contraceptives, Oral; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menstruation; Ovary; Polycystic Ovary Syndrome; Random Allocation; Testosterone; Time Factors | 2000 |
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Topics: 17-alpha-Hydroxyprogesterone; Activity Cycles; Adult; Androgen Antagonists; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Reference Values; Thyroxine | 2000 |
Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Dexamethasone; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Ovary; Pituitary-Adrenal System; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate; Ultrasonography | 2000 |
[Ovarian hyperandrogenism in adolescent girls with menstrual disorders].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Testosterone | 2002 |
151 other study(ies) available for 17-alpha-hydroxyprogesterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometr
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Chromatography, Liquid; Cosyntropin; Female; Hormones; Humans; Polycystic Ovary Syndrome; Prospective Studies; Steroids; Tandem Mass Spectrometry | 2022 |
Sensitive HPLC-DMS/MS/MS method coupled with dispersive magnetic solid phase extraction followed by in situ derivatization for the simultaneous determination of multiplexing androgens and 17-hydroxyprogesterone in human serum and its application to patien
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Chromatography, High Pressure Liquid; Female; Humans; Magnetic Phenomena; Polycystic Ovary Syndrome; Solid Phase Extraction; Tandem Mass Spectrometry | 2023 |
Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin.
Topics: 17-alpha-Hydroxyprogesterone; Adiponectin; Adipose Tissue; Adolescent; Adult; Androgens; Biomarkers; Body Mass Index; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose; Humans; Insulin; Insulin Resistance; Interleukin-6; Leptin; Luteinizing Hormone; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Sedentary Behavior; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Diagnosis, Differential; Diagnostic Techniques, Endocrine; Feasibility Studies; Female; Genetic Testing; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Reference Values; Retrospective Studies; ROC Curve; Steroid 21-Hydroxylase; Young Adult | 2020 |
Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS/MS.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Chromatography, Liquid; Female; Humans; Limit of Detection; Linear Models; Polycystic Ovary Syndrome; Reproducibility of Results; Tandem Mass Spectrometry | 2020 |
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Blood Glucose; Female; Glucose Tolerance Test; Hirsutism; Humans; Hyperandrogenism; Lipids; Melatonin; Menstrual Cycle; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Ultrasonography; Young Adult | 2018 |
Evaluation and Treatment of Hirsutism in Premenopausal Women.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Female; Hair Removal; Hirsutism; Humans; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Premenopause; Testosterone | 2018 |
Relationship between early follicular serum estrone level and other hormonal or ultrasonographic parameters in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Dehydroepiandrosterone Sulfate; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Organ Size; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography; Young Adult | 2020 |
New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Case-Control Studies; Dehydroepiandrosterone; Enzyme Activation; Female; Humans; Hyperandrogenism; Lyases; Polycystic Ovary Syndrome; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Steroid 21-Hydroxylase; Steroid Hydroxylases | 2013 |
Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Chromatography, Liquid; Female; Hormones; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Steroids; Tandem Mass Spectrometry; Testosterone; Young Adult | 2014 |
Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Alopecia; Anti-Mullerian Hormone; Biomarkers; Diagnosis, Differential; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Polycystic Ovary Syndrome; Young Adult | 2014 |
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Body Mass Index; Cholesterol; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Lipoproteins, HDL; Lipoproteins, LDL; Metabolic Diseases; Polycystic Ovary Syndrome; Prolactin; Regression Analysis; Retrospective Studies; Risk Assessment; Testosterone; Triglycerides; Waist Circumference | 2014 |
Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Age of Onset; Biomarkers; Body Mass Index; Diagnosis, Differential; Female; Hormones; Humans; Hyperandrogenism; Menstrual Cycle; Polycystic Ovary Syndrome; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Unnecessary Procedures; Young Adult | 2014 |
Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Androstenedione; Area Under Curve; Dehydroepiandrosterone Sulfate; Female; Healthy Volunteers; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Young Adult | 2015 |
Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Anti-Mullerian Hormone; Chorionic Gonadotropin; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2015 |
Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Anti-Mullerian Hormone; Biomarkers; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Luteinizing Hormone; Ovarian Follicle; Polycystic Ovary Syndrome; Prospective Studies; Ultrasonography | 2015 |
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Case-Control Studies; Cortodoxone; Dehydroepiandrosterone Sulfate; Female; Gonadotropins; Humans; Male; Middle Aged; Polycystic Ovary Syndrome; Siblings; Steroids | 2014 |
Unusual presentation with polymenorrhagia and markedly high 17-hydroxy progesterone levels in a lady with Non-Classic Congenital Adrenal Hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Diagnostic Errors; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Young Adult | 2015 |
Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Depression; Female; Humans; Libido; Orgasm; Polycystic Ovary Syndrome; Severity of Illness Index; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone | 2016 |
Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Academic Medical Centers; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Adult; Androgens; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Cross-Sectional Studies; Female; Humans; Hydrocortisone; Infusions, Intravenous; Ovarian Function Tests; Ovary; Polycystic Ovary Syndrome; Predictive Value of Tests; Time Factors; Treatment Outcome | 2016 |
Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry.
Topics: 17-alpha-Hydroxyprogesterone; Absorptiometry, Photon; Adolescent; Adult; Androgens; Body Composition; Body Mass Index; Brazil; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Young Adult | 2017 |
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Receptors, LHRH; Testosterone | 2009 |
Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Blood Glucose; C-Peptide; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Reference Values; Testosterone; Waist-Hip Ratio; Young Adult | 2009 |
Predictors of urinary albumin excretion in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Albumins; Albuminuria; Blood Glucose; Blood Pressure; C-Reactive Protein; Female; Humans; Insulin; Polycystic Ovary Syndrome; Prognosis; Risk Factors; Young Adult | 2010 |
Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Anovulation; Body Mass Index; Child, Preschool; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Luteinizing Hormone; Ovary; Pelvis; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Ultrasonography; Young Adult | 2009 |
Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Estradiol; Female; Follicular Fluid; Gonadotropins, Equine; Granulosa Cells; Humans; Mice; Mice, Transgenic; Nerve Growth Factor; Ovarian Cysts; Ovary; Polycystic Ovary Syndrome; Puberty; Reproduction; RNA, Messenger; Testosterone | 2009 |
[Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].
Topics: 17-alpha-Hydroxyprogesterone; Chorionic Gonadotropin; Diagnosis, Differential; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Metrorrhagia; Polycystic Ovary Syndrome; Postmenopause; Pregnancy; Premenopause; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Thyrotropin | 2008 |
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Prevalence; Retrospective Studies; Young Adult | 2010 |
Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS).
Topics: 17-alpha-Hydroxyprogesterone; Adiponectin; Adolescent; Body Mass Index; Case-Control Studies; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Leptin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2009 |
Investigating hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Hydrocortisone; Hyperandrogenism; Menstruation Disturbances; Polycystic Ovary Syndrome; Thyroid Diseases | 2009 |
The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
Topics: 17-alpha-Hydroxyprogesterone; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; DNA; fas Receptor; Female; Fibrinogen; Genotype; Humans; Insulin; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Testosterone; Triglycerides | 2010 |
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Amenorrhea; Diagnosis, Differential; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Insulin Resistance; Luteinizing Hormone; Middle Aged; Obesity; Oligomenorrhea; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Steroid 21-Hydroxylase; Young Adult | 2010 |
Failure to have menses following progesterone withdrawal in a normal estrogenic woman with polycystic ovarian syndrome who menstruates with oral contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Female; Humans; Polycystic Ovary Syndrome; Testosterone | 2009 |
Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?
Topics: 17-alpha-Hydroxyprogesterone; Dehydroepiandrosterone Sulfate; Fatty Liver; Female; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Pilot Projects; Polycystic Ovary Syndrome; Prolactin; Retrospective Studies; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Thyrotropin | 2010 |
Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Drug Resistance; Female; Genetic Testing; Humans; Hyperandrogenism; Point Mutation; Polycystic Ovary Syndrome; Steroid 21-Hydroxylase; Young Adult | 2010 |
Incidence of polycystic ovaries and androgen serum levels in women with borderline personality disorder.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Body Mass Index; Borderline Personality Disorder; Case-Control Studies; Comorbidity; Depression; Female; Humans; Incidence; Polycystic Ovary Syndrome; Risk Factors; Testosterone | 2010 |
Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Birth Weight; Body Mass Index; Body Size; Case-Control Studies; Estradiol; Female; Fetal Blood; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Male; Maternal Age; Polycystic Ovary Syndrome; Reference Values; Weight Gain; Young Adult | 2010 |
[Controlling effect of berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary].
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Berberine; Female; In Vitro Techniques; Insulin; Insulin Resistance; Mice; Mice, Inbred Strains; Ovary; Polycystic Ovary Syndrome; Progesterone; Testosterone | 2010 |
Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Age of Onset; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Hirsutism; Humans; Hyperandrogenism; Ovary; Polycystic Ovary Syndrome; Prevalence; Severity of Illness Index; Testosterone; Young Adult | 2010 |
[Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adult; Androstenedione; Case-Control Studies; Female; Humans; Menstrual Cycle; Poland; Polycystic Ovary Syndrome; Reference Values; Steryl-Sulfatase; Testosterone; Young Adult | 2010 |
Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Drugs, Chinese Herbal; Female; Glucose; Insulin; Insulin Resistance; Models, Animal; Ovary; Phenanthrenes; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Signal Transduction; Testosterone | 2011 |
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Anti-Mullerian Hormone; Body Mass Index; Female; Follicular Phase; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Polycystic Ovary Syndrome; Testosterone; Waist-Hip Ratio; Young Adult | 2011 |
The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Biomarkers; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Insulin; Luteinizing Hormone; Menstrual Cycle; Oligomenorrhea; Polycystic Ovary Syndrome; Predictive Value of Tests; Testosterone; Young Adult | 2011 |
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Body Mass Index; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Middle Aged; Ovary; Polycystic Ovary Syndrome; Proteins; Young Adult | 2011 |
Myeloperoxidases and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Biomarkers; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Peroxidase; Polycystic Ovary Syndrome; Young Adult | 2012 |
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Cholesterol; Female; Glucose Tolerance Test; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Polycystic Ovary Syndrome; Prolactin; Retrospective Studies; Smoking; Triglycerides; White People | 2012 |
Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Body Mass Index; Dexamethasone; Female; Glucose Tolerance Test; Humans; Ovary; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Testosterone | 2011 |
[Effects of Yangling Zhongyu Decoction on the secretion of ovarian granule cells in polycystic ovarian syndrome rat model].
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Animals; Drugs, Chinese Herbal; Estradiol; Female; Insulin-Like Growth Factor I; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, FSH; Testosterone | 2012 |
Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anti-Mullerian Hormone; Female; Follicular Phase; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Up-Regulation; Young Adult | 2013 |
Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Age Factors; Body Mass Index; Dehydroepiandrosterone Sulfate; Dental Plaque Index; Female; Gingival Crevicular Fluid; Gingivitis; Hirsutism; Humans; Hydrocortisone; Insulin; Interleukin-17; Periodontal Index; Periodontal Pocket; Periodontium; Polycystic Ovary Syndrome; Saliva; Testosterone; Young Adult | 2013 |
[Feminine pseudo-hermaphroditism and ovarian polycystic syndrome: the role of hydrocortisone].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Breast; Disorders of Sex Development; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Menarche; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 2002 |
Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Body Mass Index; Estrone; Female; Follicle Stimulating Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Periodicity; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 2002 |
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Luteinizing Hormone; Obesity; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2002 |
The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Insulin; Luteinizing Hormone; Oligomenorrhea; Polycystic Ovary Syndrome; Renin; Testosterone | 2002 |
GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adaptor Proteins, Signal Transducing; Adult; Arginine; Blood Proteins; Calcium-Binding Proteins; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Progesterone; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
The risk of functional ovarian hyperandrogenism and polycystic ovary syndrome in patients with hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Androgens; Child; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Ovarian Diseases; Ovary; Pelvis; Polycystic Ovary Syndrome; Risk Assessment; Steroid 21-Hydroxylase; Steroids; Stimulation, Chemical; Ultrasonography | 2003 |
Valproate potentiates androgen biosynthesis in human ovarian theca cells.
Topics: 17-alpha-Hydroxyprogesterone; Acetylation; Adult; Androgens; Androstenedione; Cholesterol Side-Chain Cleavage Enzyme; Dehydroepiandrosterone; Female; Gene Expression; Histones; Humans; Phosphoproteins; Polycystic Ovary Syndrome; Progesterone; Steroid 17-alpha-Hydroxylase; Theca Cells; Valproic Acid | 2004 |
The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Age Distribution; Age of Onset; Body Mass Index; Case-Control Studies; Cortodoxone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Prevalence; Steroid 21-Hydroxylase; Turkey | 2003 |
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Androstenedione; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Glucose; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2004 |
Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Alopecia; Androstenedione; Case-Control Studies; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Genetic Heterogeneity; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Menstrual Cycle; Polycystic Ovary Syndrome; Reference Values; Siblings; Testosterone | 2004 |
Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Female; Genotype; Heterozygote; Hirsutism; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Premenopause; Prevalence; Steroid 21-Hydroxylase; White People | 2005 |
[Adrenal function in girls with hirsutism].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Body Mass Index; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome | 2005 |
Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Ghrelin; Humans; Hyperandrogenism; Luteinizing Hormone; Peptide Hormones; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Homocysteine; Humans; Insulin; Lipoprotein(a); Lipoproteins; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 2005 |
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Alopecia; Androgens; Anovulation; Body Height; Body Mass Index; Body Weight; Diagnosis, Differential; Female; Hirsutism; Humans; Hyperandrogenism; Neoplasms; Ovary; Pelvis; Polycystic Ovary Syndrome; Progesterone; Retrospective Studies; Testosterone; Ultrasonography | 2006 |
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Estradiol; Female; Follicle Stimulating Hormone; Homeostasis; Humans; Hypothalamus; Insulin; Insulin Resistance; Luteinizing Hormone; Neurosecretory Systems; Obesity; Pituitary Gland; Polycystic Ovary Syndrome; Regression Analysis; Testosterone | 2005 |
Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; Inhibins; Polycystic Ovary Syndrome; Progesterone; Recombinant Proteins | 2006 |
Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Anti-Mullerian Hormone; Child; Child, Preschool; Environment; Estradiol; Female; Follicle Stimulating Hormone; Glycoproteins; Gonadotropins; Humans; Infant; Inhibins; Polycystic Ovary Syndrome; Puberty; Sex Hormone-Binding Globulin; Testicular Hormones; Testosterone | 2006 |
Functional significance of polycystic-size ovaries in healthy adolescents.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Body Mass Index; Child; Female; Humans; Insulin Resistance; Linear Models; Ovary; Polycystic Ovary Syndrome; Testosterone | 2006 |
Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Case-Control Studies; Diagnosis, Differential; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovarian Follicle; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Ultrasonography | 2006 |
Polycystic ovary syndrome and infertility.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Dexamethasone; Female; Fertility; Glucocorticoids; Humans; Ovulation Induction; Polycystic Ovary Syndrome | 2007 |
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anthropometry; Blood Glucose; Buserelin; C-Peptide; Cosyntropin; Dexamethasone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Insulin; Middle Aged; Ovarian Diseases; Phenotype; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Aged; Androstenedione; Biomarkers; Cortodoxone; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Insulin-Like Growth Factor I; Luteinizing Hormone; Middle Aged; Polycystic Ovary Syndrome; Radioimmunoassay; Steroid 21-Hydroxylase | 2008 |
Impact of obesity on the risk for polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Alabama; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Obesity; Polycystic Ovary Syndrome; Prevalence; Progesterone; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Thyrotropin | 2008 |
Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Androstenedione; Birth Weight; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Fetal Growth Retardation; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Infant, Newborn; Insulin; Luteinizing Hormone; Organ Size; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Retrospective Studies; Testosterone | 2008 |
A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Cortodoxone; Diagnosis, Differential; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prevalence; Prospective Studies; ROC Curve; Sensitivity and Specificity; Spain; Steroid 11-beta-Hydroxylase; Steroid 21-Hydroxylase | 2008 |
Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Inhibins; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2008 |
Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2008 |
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2009 |
Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Testosterone; Thyrotropin-Releasing Hormone | 1984 |
Origin of serum progestins in polycystic ovarian disease.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Dexamethasone; Female; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Progestins | 1984 |
Heterozygote detection in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Cosyntropin; Dexamethasone; Female; Genetic Carrier Screening; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Polycystic Ovary Syndrome; Radioimmunoassay; Time Factors | 1983 |
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Blood Glucose; Child; Estrone; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Growth Hormone; Hirsutism; Humans; Hydroxyprogesterones; Insulin; Insulin-Like Growth Factor Binding Protein 1; Luteinizing Hormone; Menarche; Menstruation; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Regression Analysis; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Androstenedione; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Puberty, Precocious; Testosterone; Ultrasonography | 1995 |
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Anovulation; Buserelin; Dexamethasone; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1995 |
Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Humans; Hydroxyprogesterones; Infertility, Female; Leuprolide; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1995 |
Ovarian stromal hypertrophy in hyperandrogenic women.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Anovulation; Diagnosis, Computer-Assisted; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Luteinizing Hormone; Polycystic Ovary Syndrome; Ultrasonography | 1994 |
The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Animals; Corticotropin-Releasing Hormone; Estradiol; Female; Humans; Hydroxyprogesterones; Leuprolide; Polycystic Ovary Syndrome; Sheep | 1995 |
Source localization of androgen excess in adolescent girls.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Androstenedione; Dexamethasone; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Leuprolide; Luteinizing Hormone; Ovarian Diseases; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1994 |
Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Amenorrhea; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Oligomenorrhea; Polycystic Ovary Syndrome; Prolactin; Testosterone; Ultrasonography | 1993 |
Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Blood Glucose; Body Mass Index; Female; Glucose Tolerance Test; Humans; Hydroxyprogesterones; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro.
Topics: 17-alpha-Hydroxyprogesterone; 17-Hydroxysteroid Dehydrogenases; Administration, Oral; Adrenocorticotropic Hormone; Adult; Androgens; Aromatase; Cholesterol Side-Chain Cleavage Enzyme; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Estradiol; Female; Granulosa Cells; Humans; Hydroxyprogesterones; In Vitro Techniques; Ketoconazole; Luteal Phase; Ovary; Polycystic Ovary Syndrome; Progesterone; Steroid 17-alpha-Hydroxylase; Testosterone | 1994 |
A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Androgens; Aromatase; Cortodoxone; Disorders of Sex Development; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Hypogonadism; Luteinizing Hormone; Ovary; Point Mutation; Polycystic Ovary Syndrome; Syndrome | 1994 |
17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Buserelin; Dexamethasone; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1993 |
Endovaginal Doppler flow measurements of the ovarian artery in patients with a normal menstrual cycle and with polycystic ovary syndrome during in vitro fertilization.
Topics: 17-alpha-Hydroxyprogesterone; Amenorrhea; Arteries; Blood Flow Velocity; Estradiol; Female; Fertilization in Vitro; Humans; Hydroxyprogesterones; Luteinizing Hormone; Menstrual Cycle; Ovary; Polycystic Ovary Syndrome; Ultrasonography | 1993 |
A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Female; Follicle Stimulating Hormone; Heterozygote; Homozygote; Humans; Hydrocortisone; Hydroxyprogesterones; Kinetics; Luteinizing Hormone; Male; Polycystic Ovary Syndrome; Progesterone | 1995 |
Insulin and the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Female; Humans; Hydroxyprogesterones; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Testosterone | 1996 |
Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Androgens; Cytochrome P-450 Enzyme System; Dexamethasone; Estrogens; Female; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 1996 |
17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Blood Glucose; Female; Gonadal Steroid Hormones; Humans; Insulin; Leuprolide; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Weight Loss | 1997 |
The 17 alpha-hydroxylase/17,20 lyase gene (CYP17) and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Cytochrome P-450 Enzyme System; Female; Gene Expression Regulation, Enzymologic; Humans; Hyperandrogenism; Luteinizing Hormone; Polycystic Ovary Syndrome; Polymorphism, Genetic; Steroid 17-alpha-Hydroxylase | 1997 |
Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Buserelin; C-Peptide; Female; Follicle Stimulating Hormone; Glucose; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hyperinsulinism; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Steroid 17-alpha-Hydroxylase; Testosterone; Time Factors | 1997 |
17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Buserelin; Cytochrome P-450 Enzyme System; Female; Humans; Injections, Intravenous; Ovary; Polycystic Ovary Syndrome; Reference Values; Steroid 17-alpha-Hydroxylase | 1997 |
CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Steroid 17-alpha-Hydroxylase | 1997 |
Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Cortodoxone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desoxycorticosterone; Female; Hirsutism; Homeostasis; Humans; Hyperandrogenism; Italy; Polycystic Ovary Syndrome; Steroid 21-Hydroxylase | 1997 |
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Chorionic Gonadotropin; Dehydroepiandrosterone Sulfate; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Middle Aged; Polycystic Ovary Syndrome; Testosterone; Theca Cells | 1997 |
Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Adolescent; Adult; Androstenedione; Body Composition; Body Mass Index; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Insulin; Luteinizing Hormone; Periodicity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1997 |
Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Body Weight; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Electrocoagulation; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Laparoscopy; Longitudinal Studies; Ovulation; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1998 |
Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Androgen Antagonists; Androgens; Androstenedione; Area Under Curve; Corticotropin-Releasing Hormone; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hydrocortisone; Pituitary-Adrenal System; Polycystic Ovary Syndrome; Testosterone | 1998 |
Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Body Mass Index; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone; Testosterone | 1998 |
Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
Topics: 17-alpha-Hydroxyprogesterone; Adult; Case-Control Studies; Female; Humans; Hyperandrogenism; Menstrual Cycle; Ovary; Ovulation; Polycystic Ovary Syndrome; Prevalence; Prospective Studies; Receptors, LHRH | 1999 |
The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Blood Glucose; Cytochrome P-450 Enzyme System; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Isoenzymes; Metformin; Polycystic Ovary Syndrome | 1999 |
Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Cortodoxone; Female; Humans; Kinetics; Polycystic Ovary Syndrome; Prospective Studies; Steroid 17-alpha-Hydroxylase | 1999 |
Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Blood Glucose; Body Mass Index; Female; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1999 |
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Cholesterol; Echocardiography, Doppler; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Heart; Humans; Insulin; Lipoproteins; Luteinizing Hormone; Male; Polycystic Ovary Syndrome; Prolactin; Testosterone | 1999 |
Relationship of ovarian stromal volume and serum 17-hydroxyprogesterone concentrations in patients with PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Ovary; Polycystic Ovary Syndrome | 1999 |
Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Blood Glucose; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Stimulation, Chemical; Testosterone; Time Factors | 1999 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Animals; Biological Assay; Chromatography; Female; Half-Life; Humans; Kinetics; Leydig Cells; Luteinizing Hormone; Male; Periodicity; Polycystic Ovary Syndrome; Rats; Testosterone | 1999 |
[Effects of human chorionic gonadotropine and insulin on androgen production by cultured thecal cells from patients with polycystic ovary syndrome].
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Cells, Cultured; Chorionic Gonadotropin; Female; Humans; Insulin; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Theca Cells | 1998 |
An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Blood Glucose; C-Peptide; Dehydroepiandrosterone; Factor Analysis, Statistical; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin Resistance; Ovary; Polycystic Ovary Syndrome; Reference Values; Steroid 17-alpha-Hydroxylase | 2000 |
Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Kinetics; Luteinizing Hormone; Octreotide; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 2001 |
Multiple ovarian biopsy in the treatment of women with polycystic ovary syndrome (PCOS).
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Biopsy; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2000 |
Role of the follistatin gene in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone Sulfate; Exons; Female; Follistatin; Genetic Variation; Glycoproteins; Humans; Insulin Resistance; Point Mutation; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Genetic; Sex Hormone-Binding Globulin; Testosterone; White People | 2001 |
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Amenorrhea; Androstenedione; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2001 |
Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Activity Cycles; Adolescent; Androgens; Androstenedione; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Leptin; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 2001 |
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Blood Glucose; Chorionic Gonadotropin; Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Ovary; Polycystic Ovary Syndrome; Steroids; Testosterone | 2001 |
Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Activins; Adult; Androstenedione; Blood Glucose; Body Mass Index; Female; Follicle Stimulating Hormone; Follistatin; Humans; Inhibin-beta Subunits; Insulin; Luteinizing Hormone; Obesity; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone; Regression Analysis; Testosterone | 2001 |
[Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adult; Androgens; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome | 2001 |
Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Adrenal Glands; Adult; Androstenedione; Body Composition; Body Constitution; Body Mass Index; Body Weight; Cholesterol, HDL; Fasting; Female; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Nafarelin; Ovary; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 2002 |
Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Aged; Female; Hirsutism; Humans; India; Middle Aged; Polycystic Ovary Syndrome; Postmenopause; Prolactin; Testosterone | 2002 |
Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Alleles; Androstenedione; Blood Glucose; Body Mass Index; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hirsutism; Homozygote; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Minisatellite Repeats; Polycystic Ovary Syndrome; Polymorphism, Genetic; Sex Hormone-Binding Globulin; Spain; Testosterone | 2002 |
Detection of functional ovarian hyperandrogenism in women with androgen excess.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androgens; Dexamethasone; Female; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Nafarelin; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1992 |
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Hydroxyprogesterones; Insulin; Insulin Secretion; Polycystic Ovary Syndrome; Testosterone | 1992 |
An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Analysis of Variance; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydroxyprogesterones; Insulin; Insulin-Like Growth Factor I; Obesity; Polycystic Ovary Syndrome; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 1992 |
Serum progesterone concentration is raised during early follicular phase in women with polycystic ovaries.
Topics: 17-alpha-Hydroxyprogesterone; Female; Follicular Phase; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome | 1991 |
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstenedione; Cosyntropin; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hydroxyprogesterones; Middle Aged; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1990 |
Hormonal studies on women with polycystic ovaries diagnosed by ultrasound.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 1990 |
Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Topics: 17-alpha-Hydroxyprogesterone; 17-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Adult; Androgens; Chorionic Gonadotropin; Dexamethasone; Estrogens; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Reference Values | 1990 |
Steroid responses to ACTH in women with polycystic ovaries.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Cortodoxone; Cosyntropin; Dehydroepiandrosterone; Female; Heterozygote; Humans; Hydroxyprogesterones; Middle Aged; Polycystic Ovary Syndrome; Steroids | 1989 |
[Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androgens; Estrogens; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Steroid Hydroxylases | 1989 |
Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Hydroxyprogesterones; Infertility, Female; Luteinizing Hormone; Ovarian Follicle; Ovulation Detection; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Ultrasonography | 1989 |
Adrenal cortex and type II polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Dexamethasone; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1987 |
[Relations between polycystic ovary and idiopathic hirsutism].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1988 |
Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Cosyntropin; Female; Hirsutism; Humans; Hydroxyprogesterones; Middle Aged; Polycystic Ovary Syndrome; Stimulation, Chemical | 1985 |
The effect of treatment with defined spleen dialysate on plasma levels of 21-deoxycortisol and 17-hydroxyprogesterone in women with polycystic ovary disease.
Topics: 17-alpha-Hydroxyprogesterone; 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Chorionic Gonadotropin; Cortodoxone; Dialysis; Female; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Spleen | 1985 |
Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Dehydroepiandrosterone; Diagnosis, Differential; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Hyperprolactinemia; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Testosterone; Thyroxine | 1986 |
Adrenal abnormalities in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Androgens; Dexamethasone; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Metyrapone; Polycystic Ovary Syndrome; Reference Values | 1986 |
Hormonal correlations in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Testosterone | 1986 |
Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Buserelin; Estradiol; Female; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Time Factors | 1987 |
Acute effects of bromocriptine on gonadotropin secretion in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Animals; Bromocriptine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hydroxyprogesterones; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Rodentia | 1985 |
Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenal Rest Tumor; Adult; Female; Humans; Hydroxyprogesterones; Ovarian Neoplasms; Ovary; Polycystic Ovary Syndrome | 1987 |